logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
delete
arrow
返回
J

Jin‐Yuan Shih

national taiwan university hospital

63H指数
479论文数
1.8W被引数
收录论文 126
发表时间
logo
Response to comments on “Effectiveness of amivantamab compared with real-world therapies in patients with non-small cell lung cancer with EGFR exon 20 insertion mutations post platinum-based chemotherapy”针对“与非小细胞肺癌患者中，在铂类化疗后，与真实世界疗法相比，阿曼万妥单抗的有效性”的评论
errJournal of the Formosan Medical Association
IF2.5
err2026-06-26
err0
errOAAI
errJenn-Yu Wu; Jianmin Zhuo; Ji-Fan Hsieh; Jin-Yuan Shih
err分享
err收藏
Few-Shot Lung Cancer Classification via Electronic Nose Using Large Language Models: A Multicentre Prospective Study使用大型语言模型通过电子鼻进行的少量肺癌分类: 一项多中心前瞻性研究
errRespirology
IF6.3
err2026-05-21
err0
PREAI
errMeng-Rui Lee; Chien-Chi Huang; Joyce Yue Sun; Chang-Ru Lin; Wen-Yuan Lin; Nai-Hui Chi; Kea-Tiong Tang; Jann-Yuan Wang; Chao-Chi Ho; Jin-Yuan Shih; Chong-Jen Yu
err分享
err收藏
Effectiveness of amivantamab compared with real-world therapies in patients with non-small cell lung cancer with EGFR exon 20 insertion mutations post platinum-based chemotherapy与真实世界疗法相比，氨曲单抗在携带EGFR外显子20插入突变、经铂类为基础化疗后的非小细胞肺癌患者中的疗效。
errJournal of the Formosan Medical Association
IF2.5
err2026-04-06
err0
errOAAI
errJenn-Yu Wu; Jianmin Zhuo; Yi-Chun Chen; Sheau-Pey Wang; Ji-Fan Hsieh; Jin-Yuan Shih
err分享
err收藏
Response to comments on PD-L1 expression and immune profiling cannot predict osimertinib efficacy in lung cancer with EGFR T790 M mutation: A translational study对PD-L1表达和免疫图谱的响应不能预测携带EGFR T790M突变的肺癌中奥希替尼的疗效：一项转化研究
errJournal of the Formosan Medical Association
IF2.5
err2026-04-01
err0
errOAAI
errYang, Ching-Yao; Shih, Jin-Yuan
err分享
err收藏
EGFR mutation status, treatment patterns, and outcomes in resectable early-stage non-small cell lung cancer prior to adjuvant EGFR-TKI approval: An international real-world studyEGFR突变状态、治疗模式及辅助EGFR-TKI批准前的可切除早期非小细胞肺癌的结局：一项国际真实世界研究
errLung Cancer
IF4.4
err2026-02-28
err0
PREAI
errSteven H. Lin; Doreen A Kahangire; Saurabh P Nagar; Myung-Ju Ahn; Raafet Affi; Jason Agulnik; Jin–Yuan Shih; Maximilian J Hochmair; Amanda Tufman; Didier Debieuvre; Jason Chow; Maria Jimenez; Keith L. Davis; Martin Sandelin; Rajwanth R. Veluswamy
err分享
err收藏
Clinical utility of pleural effusion supernatant cell-free DNA genotyping in previously treated patients with advanced non-small-cell lung cancer and disease progression: a multicenter retrospective study胸水上清液游离DNA基因分型在既往接受治疗且疾病进展的晚期非小细胞肺癌患者中的临床应用价值：一项多中心回顾性研究
errESMO Open
IF8.3
err2025-12-29
err0
errOAAI
errS.-C. Chang; C.-Y. Huang; Y.-C. Lai; M.-S. Hsieh; C.-C. Ho; C.-Y. Yang; J.-Y. Shih; S.-G. Wu; P.-W. Hu; C.-L. Hsu; C.-Y. Chen; W.-Y. Liao
err分享
err收藏
Real-world effectiveness of lorlatinib in previously treated ROS1 positive NSCLC patients in Taiwan台湾地区既往治疗过的ROS1阳性NSCLC患者中lorlatinib的真实世界有效性
errJournal of the Formosan Medical Association
IF2.5
err2025-11-06
err0
errOAAI
errJin-Yuan Shih; Ching-Yao Yang; Yung-Hung Luo; Gee-Chen Chang; Xuet-Yit Chen; Wei-Tse Fang
err分享
err收藏
PD-L1 regulates c-MET phosphorylation and contributes to MET-dependent resistance to osimertinib in EGFR-mutant NSCLCPD-L1调控c-MET磷酸化，并参与介导EGFR突变型NSCLC中MET依赖性对奥希替尼的耐药性。
errJournal of Biomedical Science
IF12.1
err2025-10-11
err0
errOAAI
errChia-Chi Hsu; Derek De-Rui Huang; Wei-Hsun Hsu; Min-Shu Hsieh; Fang-Yu Lin; Pei-Chen Tai; Shih-Yun Chou; Hsin-Hui Tsai; Chen-Yuan Tseng; Bin-Chi Liao; Jin-Yuan Shih; James Chih-Hsin Yang
err分享
err收藏
BOS172738, a selective RET inhibitor, for the treatment of patients with RET-altered tumors including RET-fusion-positive non-small-cell lung cancer and RET-mutant medullary thyroid cancer: a phase I dose-escalation/expansion multicenter studyBOS172738，一种选择性RET抑制剂，用于治疗RET基因变异的肿瘤患者，包括RET融合阳性的非小细胞肺癌和RET突变型甲状腺髓样癌：一项多中心I期剂量递增/扩展研究
errESMO Open
IF8.3
err2025-09-24
err0
PREAI
errP. Schöffski; A. Gazzah; J. Trigo; A. Italiano; P. Gougis; V. Subbiah; J.-Y. Shih; H.H. Loong; B. Doger; M. Keegan; B. Jeglinski; K. Andreas; B.C. Cho
err分享
err收藏
Enhanced Versus Standard Dermatologic Management With Amivantamab-Lazertinib in EGFR-Mutated Advanced NSCLC: The COCOON Global Randomized Controlled Trial增强型与标准皮肤管理联合阿曼曲妥珠单抗-拉泽替尼在EGFR突变型晚期NSCLC中的应用比较：COCOON全球随机对照试验
errJournal of Thoracic Oncology
IF20.8
err2025-09-09
err0
errOAAI
errByoung Chul Cho; Weimin Li; Alexander I. Spira; Maxwell Sauder; Jill Feldman; Farastuk Bozorgmehr; Milena Mak; Janellen Smith; Pei Jye Voon; Baogang Liu; Panwen Tian; Jiunn-Liang Tan; Cheng-Ta Yang; Jin-Yuan Shih; Nuri Karadurmus; Juan Esteban Cundom; Glaucio Bertollo; Irfan Cicin; Jorge Nieva; Ana Laura Ortega-Granados; Pascale Tomasini; Danny Nguyen; Enriqueta Felip; Julia Schuchard; Sean P. Murphy; Bailey G. Anderson; Tonatiuh Romero; Yichuan Xia; Shubin Sheng; Joshua M. Bauml; Parthiv J. Mahadevia; Julian Kam; Mehregan Nematian-Samani; Jairo Simoes; Mark Wildgust; Nicolas Girard
err分享
err收藏
Brief Report: The Effectiveness of Osimertinib in Advanced Nonsmall Cell Lung Cancer Harboring Various EGFR Exon 19 Mutation Variants简报：奥希替尼对携带各种EGFR外显子19突变变体晚期非小细胞肺癌的有效性
errClinical Lung Cancer
IF3.3
err2025-03-21
err0
errOAAI
errLih-Chyun Chang; Hsiang-Wei Hu; Min-Shu Hsieh; Shang-Gin Wu; Jin-Yuan Shih
err分享
err收藏
Clinical utility and predictive value of cerebrospinal fluid cell-free DNA profiling in non-small cell lung cancer patients with leptomeningeal metastasis脑脊液游离DNA谱在非小细胞肺癌脑膜转移中的临床应用及预测价值
errNEOPLASIA
IF7.7
err2025-02-01
err0
errOAAI
errLiang, Sheng-Kai; Liao, Wei-Yu; Shih, Jin-Yuan; Hsu, Chia-Lin; Yang, Ching-Yao; Wu, Shang-Gin; Lin, Yen-Ting; Wen, Yueh-Feng; Chen, Lun-Che; Chen, Yen-Fu; Chen, Ya-Fang; Lin, Yen-Heng; Yu, Chong-Jen
err分享
err收藏
Lipid Levels and Lung Cancer Risk: Findings from the Taiwan National Data Systems from 2012 to 2018
errJOURNAL OF EPIDEMIOLOGY AND GLOBAL HEALTH
IF3.1
err2025-01-30
err0
errOAAI
errChen, Jung-Yueh; Chi, Nai-Hui; Lee, Ho-Shen; Hsiung, Chia-Ni; Wu, Chang-Wei; Fan, Kang-Chi; Lee, Meng-Rui; Wang, Jann-Yuan; Ho, Chao-Chi; Shih, Jin-Yuan
err分享
err收藏
Preventing Infusion-Related Reactions With Intravenous Amivantamab—Results From SKIPPirr, a Phase 2 Study: A Brief Report预防静脉注射Amivantamab相关反应：SKIPPirr一项2期研究的成果——简报
errJournal of Thoracic Oncology
IF20.8
err2025-01-24
err0
errOAAI
errAlexander I. Spira; Luis Paz-Ares; Ji-Youn Han; Jin-Yuan Shih; Céline Mascaux; Upal Basu Roy; Jon Zugazagoitia; Yu Jung Kim; Chao-Hua Chiu; Sang-We Kim; Ernest Nadal; Ignacio Gil-Bazo; Sean P. Murphy; Bailey G. Anderson; Yichuan Xia; George Wang; Joshua M. Bauml; Marc Chioda; Jairo Simoes; Parthiv J. Mahadevia; Gilberto Lopes
err分享
err收藏
Atezolizumab, bevacizumab, pemetrexed and platinum for EGFR-mutant NSCLC patients after EGFR TKI failure: A phase II study with immune cell profile analysisAtezolizumab，bevacizumab，培美曲塞和铂类用于EGFR TKI失败后的EGFR突变NSCLC患者: 免疫细胞谱分析的II期研究
errCLINICAL AND TRANSLATIONAL MEDICINE
IF6.8
err2024-12-23
err0
errOAAI
errWu, Shang-Gin; Ho, Chao-Chi; Yang, James Chih-Hsin; Yu, Shu-Han; Lin, Yen-Feng; Lin, Shu-Chin; Liao, Bin-Chi; Yang, Ching-Yao; Lin, Yen-Ting; Yu, Chong-Jen; Chuang, Ya-Ting; Liao, Wei-Yu; Yap, Kah Yi; Kou, Weng Si; Shih, Jin-Yuan
err分享
err收藏
PD-L1 expression and immune profiling cannot predict osimertinib efficacy in lung cancer with EGFR T790 M mutation: A translational studyPD-L1表达和免疫谱分析无法预测携带EGFR T790 M突变的肺癌中osimertinib的疗效：一项转化研究
errJournal of the Formosan Medical Association
IF2.5
err2024-12-17
err0
errOAAI
errChing-Yao Yang; Wei-Yu Liao; Chao-Chi Ho; Kuan-Yu Chen; Tzu-Hsiu Tsai; Chia-Lin Hsu; Kang-Yi Su; Yih-Leong Chang; Chen-Tu Wu; Chia-Chi Hsu; Yi-Nan Liu; Guan-Ru Peng; Almanzo Aeterna Kangartaputra; Shu-Han Yu; Bin-Chi Liao; Wei-Hsun Hsu; Jih-Hsiang Lee; Chia-Chi Lin; Jin-Yuan Shih; James Chih-Hsin Yang
err分享
err收藏
RELAY: Final Overall Survival for Erlotinib Plus Ramucirumab or Placebo in Untreated, EGFR-Mutated Metastatic NSCLCRELAY研究：厄洛替尼联合ramucirumab或安慰剂在未治疗、EGFR突变型转移性NSCLC中的最终总生存期
errJOURNAL OF THORACIC ONCOLOGY
IF20.8
err2024-11-01
err5
PREAI
errNakagawa, Kazuhiko; Garon, Edward B.; Seto, Takashi; Nishio, Makoto; Aix, Santiago Ponce; Paz-Ares, Luis; Chiu, Chao-Hua; Park, Keunchil; Novello, Silvia; Nadal, Ernest; Nishino, Kazumi; Yoh, Kiyotaka; Shih, Jin-Yuan; Chik, Jeannie Y. K.; Moro-Sibilot, Denis; Puri, Tarun; Varughese, Sunoj Chacko; Frimodt-Moller, Bente; Visseren-Grul, Carla; Reck, Martin
err分享
err收藏
Real-world analysis of survival outcomes in advanced EGFR-mutant NSCLC patients treated with platinum-pemetrexed after EGFR-TKI treatment failure真实世界中EGFR突变型晚期非小细胞肺癌患者经EGFR-TKI治疗后失败，接受铂类-培美曲塞治疗的生存结局分析
errJournal of the Formosan Medical Association
IF2.5
err2024-08-16
err0
errOAAI
errZong-Han Yao; Wei-Yu Liao; Chin-Yao Yang; Chao-Chi Ho; Jin-Yuan Shih; Kuan-Yu Chen; James Chih-Hsin Yang; Chong-Jen Yu
err分享
err收藏
Hope and its relationship with treatment/ physical related factors in lung cancer patients receiving immunotherapy希望及其与接受免疫治疗肺癌患者的治疗/身体相关因素的关系
errJournal of the Formosan Medical Association
IF2.5
err2024-07-06
err0
errOAAI
errChih-Chien Hsu; Yun-Hsiang Lee; Min-Ru Chen; Chih-Hsin Yang; Jin-Yuan Shih; Wei-Yu Liao; Meng-Ping Hsiao; Yeur-Hur Lai
err分享
err收藏
miR-204 suppresses cancer stemness and enhances osimertinib sensitivity in non-small cell lung cancer by targeting CD44miR-204通过靶向CD44抑制非小细胞肺癌的癌症干细胞并增强奥希替尼的敏感性
errMOLECULAR THERAPY NUCLEIC ACIDS
IF6.1
err2024-03-01
err5
errOAAI
errWu, Shang-Gin; Chang, Tzu-Hua; Tsai, Meng-Feng; Liu, Yi-Nan; Huang, Yen-Lin; Hsu, Chia-Lang; Jheng, Han-Nian; Shih, Jin-Yuan
err分享
err收藏

研究方向

暂无研究方向
合作学者
合作期刊
M
Marc Ladanyi
H 指数: 204 · 论文数: 2.5K
G
Gabriel N. Hortobágyi
H 指数: 187 · 论文数: 1.9K
M
Mien‐Chie Hung
H 指数: 163 · 论文数: 1.5K
A
Adi F. Gazdar
H 指数: 161 · 论文数: 1.2K
V
Valerie W. Rusch
H 指数: 161 · 论文数: 1.1K
查看更多